Testing effectiveness (Phase 2)Study completedNCT02675829
What this trial is testing
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Who this might be right for
Solid Tumor CancersLung CancerBladder Cancer+1 more
Memorial Sloan Kettering Cancer Center 131